Edition:
India

Victrex PLC (VCTX.L)

VCTX.L on London Stock Exchange

2,306.00GBp
29 Jan 2020
Change (% chg)

16.00 (+0.70%)
Prev Close
2,290.00
Open
2,286.00
Day's High
2,316.00
Day's Low
2,262.00
Volume
172,635
Avg. Vol
230,589
52-wk High
2,574.00
52-wk Low
1,813.68

Summary

Name Age Since Current Position

Lawrence Pentz

2014 Non-Executive Independent Chairman of the Board

Jakob Sigurdsson

56 2017 Chief Executive Officer, Executive Director

Richard Armitage

2019 Chief Financial Officer, Executive Director

Martin Court

56 2019 Executive Director, Chief Commercial Officer

Janet Ashdown

2018 Non-Executive Independent Director

Brendan Connolly

2018 Non-Executive Independent Director

Pamela Kirby

66 2014 Senior Non-Executive Independent Director

David Thomas

2018 Non-Executive Independent Director

Jane Toogood

2015 Non-Executive Independent Director

Andrew Hanson

Director of Investor Relations and Corporate Communications

Biographies

Name Description

Lawrence Pentz

Mr. Lawrence C. Pentz serves as Non-Executive Independent Chairman of the Board of the Company. Over 30 years at Johnson Matthey Plc in a variety of senior roles. He was instrumental in the acquisition and integration of multiple catalyst and chemical companies and was an executive director responsible for the Emission Control Technologies business of Johnson Matthey Plc. Larry retired as an executive director of Johnson Matthey Plc during 2016 where he held board-level responsibility for Johnson Matthey’s process technologies and fine chemical divisions, as well as group-level responsibilities for operational excellence and environmental, health and safety. Larry has over 30 years’ service within multinational corporations in a variety of operational and general management positions, with extensive experience in developing strategy for and successfully leading international growth businesses.

Jakob Sigurdsson

Mr. Jakob Oskar Sigurdsson serves as Chief Executive Officer, Executive Director of the Company. Jakob has more than 20 years’ experience in large multinational companies, both listed and private, including nine years with Rohm & Haas (now part of Dow Chemical) in the US, as well as chief executive of food manufacturer Alfesca in Europe and as chief executive of Promens. Between September 2016 and June 2017, Jakob was chief executive officer of VÍS, the largest Icelandic insurance and re-insurance company. Jakob holds a BSc in chemistry from the University of Iceland and an MBA from Northwestern University in the US. His executive responsibilities have spanned marketing, supply chain, business development, strategy and M&A, with particular emphasis on growth in new or developing markets.

Richard Armitage

Mr. Richard Armitage serves as Chief Financial Officer, Executive Director of the Company. Group finance director of Samworth Brothers, a UK-based branded and own-label food manufacturer, which he joined in 2014. Prior to Samworth Brothers Richard was chief financial officer of McBride plc. His other roles include finance director for Premier Foods plc’s grocery and chilled divisions, and at Courtaulds, ICI and Boots plc. Richard trained through the Courtaulds and ICI management development programmes.

Martin Court

Mr. Martin L. Court serves as Executive Director, Chief Commercial Officer of the Company. Martin joined Victrex in February 2013 as Managing Director of Invibio, Victrex’s medical business. Martin is now the Company’s Chief Commercial Officer. Martin has significant proven international experience in the medical and high performance materials and chemicals industries, including with Cytec Industries, and in a number of senior roles at both ICI and UCB. Martin is an INSEAD alumnus and holds a doctorate in the field of surface chemistry and fracture mechanics and a BSc (Eng) degree in mineral technology from Imperial College of Science and Technology.

Janet Ashdown

Ms. Janet E. Ashdown serves as Non-Executive Independent Director of the Company. Janet has a distinguished career working for BP plc for over 30 years, holding a number of international positions most recently as director, BP Oil UK Limited and also head of UK retail and commercial fuels and non-executive of SIG Plc. Janet has over 30 years’ experience of the international energy sector in a variety of senior executive roles. Janet is currently non-executive director and senior independent director of Marshalls plc and is chair of its remuneration committee. She is also an independent non-executive director of RHI Magnesita N.V.

Brendan Connolly

Mr. Brendan W. Connolly serves as Non-Executive Independent Director of the Company. Brendan was a senior executive at Intertek Group plc and had previously been chief executive officer of Moody International (which was acquired by Intertek in 2011). Prior to Moody, he was managing director of Atos Origin UK, and spent more than 25 years of his career with Schlumberger in senior international roles over three continents. Brendan has over 35 years’ experience in the international oil and gas industry serving in a number of senior executive roles. Brendan is a non-executive director and senior independent director of Synthomer plc, in addition to being chairman of its remuneration committee and member of its audit and nomination committees. Brendan is also on two private equity boards, one of which he chairs.

Pamela Kirby

Dr. Pamela J. Kirby Ph.D. is no longer serves as Senior Non-Executive Independent Director of the Company effective 2/6/2020. Pamela has held a number of other senior positions in the international pharmaceutical industry including at AstraZeneca PLC, where she was a regional director, and F. Hoffmann-La Roche Ltd, where she was director of strategic marketing and business development. Pamela was formerly CEO of Quintiles Transnational Corp. Pamela has extensive knowledge of the international healthcare sector. She is an experienced company board director having previously served as chairman of Scynexis Inc and Oxford Immunotec Limited. She was SID at Informa plc and a non-executive director of several boards including Smith & Nephew plc and Novo-Nordisk A/S. Pamela is a non-executive director of DCC plc, Hikma Pharmaceuticals plc and Reckitt Benckiser Group plc, serves on the supervisory board of Akzo Nobel and is also an advisor to Kings Health Partnership.

David Thomas

Mr. David Thomas serves as Non-Executive Independent Director of the Company. David was chief financial officer at Invensys plc from 2011 until his retirement in 2014, having held senior roles across the business since 2002. Prior to joining Invensys, he was a senior partner in Ernst & Young (‘E&Y’), specialising in long-term industrial contracting businesses and is a former member of the Auditing Practices Board. David is a non-executive director and chair of the audit committee at Dialight Plc.

Jane Toogood

Ms. Jane E. Toogood serves as Non-Executive Independent Director of the Company. Borealis, ICI and Uniqema, and also held a non-executive director role with NHS Harrogate and District Foundation Trust. Jane has a wealth of experience across a number of business management, senior commercial and business development roles within the global chemical industry and holds an MA in natural sciences (chemistry) from the University of Oxford. Jane is the sector chief executive, efficient natural resources at Johnson Matthey Plc.

Andrew Hanson

Basic Compensation

Name Fiscal Year Total

Lawrence Pentz

201,600

Jakob Sigurdsson

763,672

Richard Armitage

445,073

Martin Court

710,629

Janet Ashdown

58,000

Brendan Connolly

48,000

Pamela Kirby

55,500

David Thomas

58,000

Jane Toogood

48,000

Andrew Hanson

--
As Of  30 Sep 2019